Recordati (Italy)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 55 papers

  • Open Access
  • Research Article

SUN-073 Long-Term Safety of Pasireotide in Patients With Cushing's Disease: Final Results From a 10-Year Open-Label Phase IV Rollover Study (B2412)

  • Oct 01, 2025
  • Journal of the Endocrine Society
  • Wilson Gallardo +10
  • Open Access
  • Research Article
  • Citations17

Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)

  • Jan 01, 2024
  • Endocrine Journal
  • Akira Shimatsu +12
  • Open Access
  • Research Article

THU038 Osilodrostat Dosing In Cushing’s Disease: A Pooled Analysis Of The LINC Program

  • Oct 05, 2023
  • Journal of the Endocrine Society
  • John Newell-Price +10
  • Open Access
  • Abstract
  • Citations1

Abstract #1183049: Hypertension (HTN) and Diabetes (DM) Improvement During Osilodrostat Therapy in Patients with Cushing’s Disease (CD): Analyses from the Phase III LINC 3 study

  • May 01, 2022
  • Endocrine Practice
  • Rosario Pivonello +7
  • Abstract
  • Citations3

Abstract #999926: Effect of Dosing and Titration of Osilodrostat on Efficacy and Safety in Patients With Cushing's Disease (CD): Results From Two Phase III Trials (LINC3 and LINC4)

  • May 28, 2021
  • Endocrine Practice
  • Maria Fleseriu +10
  • Abstract

PO-01-076 Patterns of national health system reimbursed prescription for erectile dysfunction: An ecological population-based study

  • Apr 29, 2019
  • The Journal of Sexual Medicine
  • P Capogrosso +6
  • Open Access
  • Research Article
  • Citations21

Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells

  • Feb 25, 2019
  • European Journal of Medicinal Chemistry
  • Fabio Del Bello +10
  • Research Article
  • Citations12

Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT1A receptor agonists for CNS disorders and neuropathic pain.

  • Jul 25, 2018
  • Future Medicinal Chemistry
  • Silvia Franchini +13
  • Open Access
  • Research Article
  • Citations19

The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes

  • Sep 09, 2016
  • European Journal of Medicinal Chemistry
  • Fabio Del Bello +14
  • Dataset

Faculty Opinions recommendation of Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.

  • Sep 17, 2012
  • Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  • Rodolfo Testa
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.